Meeting
2021 ASCO Annual Meeting
Risk-reducing salpingo-oophorectomy and breast cancer incidence among BRCA-mutation carriers.
Authors
Tamar Perri
Gynecologic Oncology Department, Sheba Medical Center, Ramat Gan, Israel
Tamar Perri , Shani Naor-Ravel , Perry Eliassi-Revivo , Dror Lifshitz , Eitan Friedman , Jacob Korach
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10548)
DOI
10.1200/JCO.2021.39.15_suppl.10548
Abstract #
10548
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Pathologic findings at risk-reducing salpingo-oophorectomy among women at increased ovarian cancer risk: Results from GOG-199.
First Author: Phuong L. Mai
Poster
2018 ASCO Annual Meeting
The association of BRCA1 and BRCA2 mutations on prostate cancer risk, frequency, and mortality: Systematic review and meta-analysis.
First Author: Mok Oh
Poster
2016 ASCO Annual Meeting
Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).
First Author: Philipp Harter
Poster
2015 Breast Cancer Symposium
Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer.
First Author: Nimmi S. Kapoor